Private Advisor Group LLC Has $405,000 Stock Position in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Private Advisor Group LLC lowered its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 19.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 28,108 shares of the company’s stock after selling 6,733 shares during the quarter. Private Advisor Group LLC’s holdings in BlackRock Health Sciences Term Trust were worth $405,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of BMEZ. Brown Brothers Harriman & Co. bought a new position in BlackRock Health Sciences Term Trust during the third quarter worth about $32,000. K2 Principal Fund L.P. bought a new stake in shares of BlackRock Health Sciences Term Trust during the third quarter worth approximately $158,000. Jane Street Group LLC bought a new stake in shares of BlackRock Health Sciences Term Trust during the third quarter worth approximately $357,000. Kingswood Wealth Advisors LLC bought a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth approximately $420,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth approximately $471,000.

BlackRock Health Sciences Term Trust Stock Performance

Shares of BMEZ stock opened at $15.45 on Wednesday. BlackRock Health Sciences Term Trust has a 1 year low of $14.27 and a 1 year high of $16.75. The stock has a 50 day simple moving average of $15.69 and a 200 day simple moving average of $15.67.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently declared a dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be issued a dividend of $0.1763 per share. The ex-dividend date is Friday, March 14th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.